vs

Side-by-side financial comparison of GLAUKOS Corp (GKOS) and HIVE Digital Technologies Ltd. (HIVE). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $93.1M, roughly 1.6× HIVE Digital Technologies Ltd.). GLAUKOS Corp runs the higher net margin — 6.2% vs -98.1%, a 104.3% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 41.2%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 25.4%).

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

GKOS vs HIVE — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.6× larger
GKOS
$150.6M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+177.4% gap
HIVE
218.6%
41.2%
GKOS
Higher net margin
GKOS
GKOS
104.3% more per $
GKOS
6.2%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
25.4%
GKOS

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
GKOS
GKOS
HIVE
HIVE
Revenue
$150.6M
$93.1M
Net Profit
$9.4M
$-91.3M
Gross Margin
77.9%
-27.1%
Operating Margin
9.0%
Net Margin
6.2%
-98.1%
Revenue YoY
41.2%
218.6%
Net Profit YoY
-234.0%
EPS (diluted)
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GKOS
GKOS
HIVE
HIVE
Q1 26
$150.6M
Q4 25
$143.1M
$93.1M
Q3 25
$133.5M
$87.3M
Q2 25
$124.1M
$45.6M
Q1 25
$106.7M
Q4 24
$105.5M
$29.2M
Q3 24
$96.7M
$22.6M
Q2 24
$95.7M
$32.2M
Net Profit
GKOS
GKOS
HIVE
HIVE
Q1 26
$9.4M
Q4 25
$-133.7M
$-91.3M
Q3 25
$-16.2M
$-15.8M
Q2 25
$-19.7M
$35.0M
Q1 25
$-18.1M
Q4 24
$-33.6M
$68.2M
Q3 24
$-21.4M
$80.0K
Q2 24
$-50.5M
$-18.3M
Gross Margin
GKOS
GKOS
HIVE
HIVE
Q1 26
77.9%
Q4 25
-1.1%
-27.1%
Q3 25
78.4%
4.7%
Q2 25
78.3%
-13.6%
Q1 25
77.2%
Q4 24
72.9%
-43.7%
Q3 24
76.6%
-66.1%
Q2 24
76.4%
-7.4%
Operating Margin
GKOS
GKOS
HIVE
HIVE
Q1 26
9.0%
Q4 25
-97.7%
Q3 25
-12.3%
Q2 25
-18.3%
Q1 25
-19.4%
Q4 24
-27.2%
Q3 24
-25.5%
Q2 24
-31.3%
Net Margin
GKOS
GKOS
HIVE
HIVE
Q1 26
6.2%
Q4 25
-93.4%
-98.1%
Q3 25
-12.2%
-18.1%
Q2 25
-15.8%
76.8%
Q1 25
-17.0%
Q4 24
-31.8%
233.2%
Q3 24
-22.1%
0.4%
Q2 24
-52.8%
-56.7%
EPS (diluted)
GKOS
GKOS
HIVE
HIVE
Q1 26
Q4 25
$-2.34
$-0.38
Q3 25
$-0.28
$-0.07
Q2 25
$-0.34
$0.18
Q1 25
$-0.32
Q4 24
$-0.56
$0.52
Q3 24
$-0.39
$0.00
Q2 24
$-1.00
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GKOS
GKOS
HIVE
HIVE
Cash + ST InvestmentsLiquidity on hand
$276.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$670.9M
$559.3M
Total Assets
$893.3M
$624.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GKOS
GKOS
HIVE
HIVE
Q1 26
$276.7M
Q4 25
$90.8M
Q3 25
$98.2M
Q2 25
$100.8M
Q1 25
$114.3M
Q4 24
$169.6M
$40.5M
Q3 24
$100.1M
$31.7M
Q2 24
$68.1M
Stockholders' Equity
GKOS
GKOS
HIVE
HIVE
Q1 26
$670.9M
Q4 25
$656.2M
$559.3M
Q3 25
$769.5M
$624.6M
Q2 25
$765.1M
$560.5M
Q1 25
$764.0M
Q4 24
$766.9M
$430.9M
Q3 24
$668.5M
$275.5M
Q2 24
$665.2M
$268.6M
Total Assets
GKOS
GKOS
HIVE
HIVE
Q1 26
$893.3M
Q4 25
$893.5M
$624.0M
Q3 25
$999.4M
$693.0M
Q2 25
$987.0M
$628.7M
Q1 25
$966.2M
Q4 24
$974.8M
$478.6M
Q3 24
$926.5M
$334.7M
Q2 24
$919.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GKOS
GKOS
HIVE
HIVE
Operating Cash FlowLast quarter
$46.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GKOS
GKOS
HIVE
HIVE
Q1 26
Q4 25
$6.8M
$46.0M
Q3 25
$-10.1M
$-10.6M
Q2 25
$7.0M
$10.2M
Q1 25
$-18.5M
Q4 24
$507.0K
$-28.5M
Q3 24
$-9.6M
$-2.2M
Q2 24
$-18.4M
$-4.4M
Free Cash Flow
GKOS
GKOS
HIVE
HIVE
Q1 26
Q4 25
$3.9M
Q3 25
$-11.7M
Q2 25
$5.8M
Q1 25
$-20.5M
Q4 24
$-1.2M
$-55.5M
Q3 24
$-11.0M
$-34.7M
Q2 24
$-20.5M
FCF Margin
GKOS
GKOS
HIVE
HIVE
Q1 26
Q4 25
2.7%
Q3 25
-8.8%
Q2 25
4.7%
Q1 25
-19.2%
Q4 24
-1.2%
-189.9%
Q3 24
-11.4%
-153.4%
Q2 24
-21.4%
Capex Intensity
GKOS
GKOS
HIVE
HIVE
Q1 26
Q4 25
2.0%
Q3 25
1.2%
Q2 25
0.9%
Q1 25
1.8%
Q4 24
1.6%
92.5%
Q3 24
1.5%
143.9%
Q2 24
2.2%
Cash Conversion
GKOS
GKOS
HIVE
HIVE
Q1 26
Q4 25
Q3 25
Q2 25
0.29×
Q1 25
Q4 24
-0.42×
Q3 24
-26.94×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons